Loading…
Prelude Therapeutics Incorporated is projected to rise to $5.45 by 2027, a +19% move from its current price of $4.60. PRLD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $4.37 | $4.60 | $4.85 | +0.04% |
| Aug 4 | $4.28 | $4.60 | $4.95 | +0.08% |
| Aug 5 | $4.21 | $4.61 | $5.04 | +0.12% |
| Aug 6 | $4.16 | $4.61 | $5.11 | +0.17% |
| Aug 7 | $4.11 | $4.61 | $5.17 | +0.21% |
| Aug 8 | $4.06 | $4.61 | $5.23 | +0.25% |
| Aug 9 | $4.03 | $4.61 | $5.29 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.03 | $4.61 | $5.29 | +0.29% |
| Week 2 | $3.82 | $4.63 | $5.61 | +0.58% |
| Week 3 | $3.66 | $4.64 | $5.88 | +0.87% |
| Week 4 | $3.54 | $4.65 | $6.11 | +1.16% |
| Week 5 | $3.44 | $4.67 | $6.33 | +1.46% |
| Week 6 | $3.35 | $4.68 | $6.54 | +1.75% |
| Week 7 | $3.27 | $4.69 | $6.73 | +2.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company focused on discovering and developing novel precision cancer medicines for underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis, polycythemia vera, and essential thrombocythemia. It is also developing KAT6A for the treatment of advanced breast cancer and other solid tumors, and mutated calreticulin degrader antibody conjugates to treat MF and ET.
The company has collaboration with AbCellera Biologics to discover, develop, and commercialize novel degrader antibody conjugates. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated (PRLD) is a healthcare company focused on oncology. Its current price is $4.60 and its market capitalization is $366.37M, with a market rank of 3267.
The price outlook, based on the provided forecasts, suggests upside potential over the coming years, including an average price of $12.17 by 2030 (ROI 164.5, bullish), $28.67 by 2040 (ROI 523.3, bullish), and $70.81 by 2050 (ROI 1439.3, bullish).
Earlier forecast milestones include 2026 avg $4.60, 2027 avg $5.45, 2028 avg $8.62, and 2029 avg $10.60, illustrating continued upward trajectory through 2050.
A major floor 33.7% below — a decisive break under it would weaken the trend.
The nearest floor, 16.7% below — buyers have tended to step in here.
The nearest ceiling, 15.9% above — a clean break opens room to run.
A major ceiling 32.3% above — clearing it would confirm fresh momentum.
Key PRLD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PRLD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.58 | Buy | $4.59 | Buy |
| MA 10 | $4.27 | Buy | $4.46 | Buy |
| MA 20 | $4.46 | Buy | $4.42 | Buy |
| MA 50 | $4.33 | Buy | $4.35 | Buy |
| MA 100 | $4.21 | Buy | $4.03 | Buy |
| MA 200 | $3.12 | Buy | $3.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.52 | Neutral |
| Stoch RSI (14) | 63.15 | Neutral |
| CCI (20) | 25.87 | Neutral |
| Williams %R (14) | -36.89 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 3.14 | Buy |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 63.11 | Neutral |
| TRIX (15) | -0.12 | Sell |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 62.16 | Neutral |
| Momentum (10) | 0.40 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 5.01 | Sell |
| ADX (14) | 16.71 | Neutral |
| ATR (14) | 0.20 | Info |
The 30-day technical picture for PRLD is bullish.
RSI(14) is 50, with the 50-day simple moving average at $4.33 and the 200-day simple moving average at $3.12. Key technical levels are a support at $3.83 and a resistance at $5.33.
The 30-day trading range spans from $3.27 to $6.46, indicating recent price activity within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.81 | $4.60 | $6.99 | 0% | Neutral | |
| $4.00 | $5.45 | $8.03 | +19% | Neutral | |
| $5.96 | $8.62 | $13.52 | +87% | Bullish | |
| $6.97 | $10.60 | $17.44 | +130% | Bullish | |
| $7.65 | $12.17 | $20.83 | +165% | Bullish | |
| $8.24 | $13.67 | $24.22 | +197% | Bullish | |
| $6.84 | $11.82 | $21.58 | +157% | Bullish | |
| $7.59 | $13.63 | $25.57 | +196% | Bullish | |
| $10.07 | $18.77 | $36.07 | +308% | Bullish | |
| $11.68 | $22.58 | $44.40 | +391% | Bullish | |
| $12.90 | $28.67 | $61.86 | +523% | Bullish | |
| $31.86 | $70.81 | $162.86 | +14.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.81 | $4.60 | $5.73 | +0.00% |
| September 2026 | $3.69 | $4.48 | $5.68 | -2.53% |
| October 2026 | $3.88 | $4.78 | $6.17 | +6.53% |
| November 2026 | $4.22 | $5.25 | $6.89 | +9.96% |
| December 2026 | $4.19 | $5.26 | $6.99 | +0.12% |
Click any year to see its month-by-month PRLD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PRLD to range from $1.81 to $6.99 through 2026. The $4.60 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The PRLD price prediction for 2027 points to an average of $5.45 (low $4.00, high $8.03) — a potential gain of +19% on today's $4.60. Price action looks broadly range-bound.
In 2028, PRLD is projected to trade between $5.96 and $13.52, averaging $8.62 — a potential gain of +87% from today's $4.60. That is up +58% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Prelude Therapeutics Incorporated's 2029 outlook centres on $10.60, within a $6.97 to $17.44 range. That is up +23% on the projected 2028 average. That marks a +130% change versus current levels. Momentum favours further upside here.
By 2030, PRLD could reach as high as $20.83, with a base case around $12.17 and support toward $7.65 — roughly +165% from $4.60. Buyers look set to stay in control over this stretch.
Expect PRLD to range from $8.24 to $24.22 through 2031. The $13.67 average target implies a +197% move from current prices. That is up +12% on the projected 2030 average. Momentum favours further upside here.
The PRLD price prediction for 2032 points to an average of $11.82 (low $6.84, high $21.58) — a potential gain of +157% on today's $4.60. Buyers look set to stay in control over this stretch.
In 2033, PRLD is projected to trade between $7.59 and $25.57, averaging $13.63 — a potential gain of +196% from today's $4.60. That is up +15% on the projected 2032 average. Momentum favours further upside here.
Prelude Therapeutics Incorporated's 2034 outlook centres on $18.77, within a $10.07 to $36.07 range. That is up +38% on the projected 2033 average. That marks a +308% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, PRLD could reach as high as $44.40, with a base case around $22.58 and support toward $11.68 — roughly +391% from $4.60. Momentum favours further upside here.
Expect PRLD to range from $12.90 to $61.86 through 2040. The $28.67 average target implies a +523% move from current prices. That is up +27% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The PRLD price prediction for 2050 points to an average of $70.81 (low $31.86, high $162.86) — a potential gain of +14.4x on today's $4.60. Momentum favours further upside here.
Investing $1,000 in PRLD today (≈ 217.391304 PRLD) could be worth
$15,393.41
+$14,393.41 (+1439%) by 2050 · US Dollar
Based on the average projected PRLD price of $70.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PRLDwould be worth at today's price.
$1,000 invested in PRLD on Jul 31, 2025 (≈ 1,282.051329 PRLD) would be worth
$5,897.44
+$4,897.44 (+489.7%) today · 5.90× · US Dollar
Based on a PRLD entry price of $0.78 vs. today's $4.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.83 | $1,201.04 | +20.1% |
| 1 month ago | $4.91 | $936.86 | -6.3% |
| 3 months ago | $4.7 | $978.72 | -2.1% |
| 6 months ago | $2.03 | $2,266.01 | +126.6% |
| 1 year ago | $0.78 | $5,897.44 | +489.7% |
| All time (5.0y) ago | $32 | $143.75 | -85.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PRLD forecast.
Our base-case forecast reaches $9.20 around 2029.
Implied market cap at $9.20: $597.24M
The multi-year forecast paints a clearly bullish path, with 2030 avg $12.17 and ROI 164.5, 2040 avg $28.67 and ROI 523.3, and 2050 avg $70.81 and ROI 1439.3. The sentiment aligns with this longer horizon, remaining BULLISH for 2028 onward.
Other forecast anchors show gradual upside: 2026 avg $4.60, 2027 avg $5.45 (ROI 18.6), 2028 avg $8.62, 2029 avg $10.60, 2031 avg $13.67, 2032 avg $11.82, 2033 avg $13.63, 2034 avg $18.77, 2035 avg $22.58. These figures illustrate a path of expanding value into the 2030s and beyond, capped by the 2050 upside of avg $70.81 and max $162.86.
As with any forecast, these are estimates and not guarantees; actual results depend on numerous factors including clinical progress, regulatory outcomes, and market conditions.
Tap a question to reveal the answer.
Avg $12.17, min $7.65, max $20.83, ROI 164.5, sentiment BULLISH.
The forecast shows a bullish trajectory from 2028 onward with higher averages: 2028 avg $8.62, 2029 avg $10.60, 2030 avg $12.17, 2040 avg $28.67, and 2050 avg $70.81. ROIs rise to 164.5 by 2030 and 1439.3 by 2050, with sentiment labeled BULLISH in later years.
The 2050 max forecast is $162.86, so reaching $100 is within the forecast range.
Current price $4.60; market cap $366.37M.
Sentiment BULLISH; RSI14 50; SMA50 $4.33; SMA200 $3.12; support $3.83; resistance $5.33; 30-day range $3.27-$6.46.
Prelude Therapeutics Incorporated Community Discussion
0Share your Prelude Therapeutics Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.